Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis.
about
Pathogenesis of Type 2 Epithelial to Mesenchymal Transition (EMT) in Renal and Hepatic FibrosisDiscovery of cytoglobin and its roles in physiology and pathology of hepatic stellate cellsEpistemology of the origin of cancer: a new paradigm.Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice.The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.Acteoside-mediates chemoprevention of experimental liver carcinogenesis through STAT-3 regulated oxidative stress and apoptosis.Soy Protein Isolate Protects Against Ethanol-Mediated Tumor Progression in Diethylnitrosamine-Treated Male MiceCharacterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human diseaseOncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotypeRegenerative toxicology: the role of stem cells in the development of chronic toxicities.The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations.Alcohol and Cancer: Mechanisms and Therapies.Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular CarcinomaChemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction.(Z)-3,5,4'-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell-Cycle Progression.Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats.Differentially expressed MicroRNAs provide mechanistic insight into fibrosis-associated liver carcinogenesis in mice.Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.A mouse model of alcoholic liver fibrosis-associated acute kidney injury identifies key molecular pathways.H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule.Hepatocyte autotaxin expression promotes liver fibrosis and cancer.Genetic lineage tracing analysis of the cell of origin of hepatotoxin-induced liver tumors in mice.PTEN and TRAIL genes loaded zein nanoparticles as potential therapy for hepatocellular carcinoma.Epigenetically mediated inhibition of S-adenosylhomocysteine hydrolase and the associated dysregulation of 1-carbon metabolism in nonalcoholic steatohepatitis and hepatocellular carcinoma.Increased systemic zonula occludens 1 associated with inflammation and independent biomarker in patients with hepatocellular carcinoma.Fibrosis-associated hepatocarcinogenesis revisited: Establishing standard medium-term chemically-induced male and female models
P2860
Q26771232-7DDEAF0E-0E2A-4582-B6B0-CECDAEA8E30AQ28077936-4E1987C2-85D5-42CF-AB39-97F01E10B971Q33631655-97A49F24-556C-4816-AFCA-3EA6074BC590Q34403470-4CFC13FB-10CF-4D6C-9EC7-1011AEDD9290Q34427004-67763C13-F347-4F58-AF8B-D71B7FADC1D4Q35962400-5EC15291-13DB-4568-85E7-04186C0B19BBQ35967096-ED874985-944C-454C-B736-0248F1DA19ABQ36706884-B2D3F1C9-401B-4FAB-B0DB-0E85EDEDD337Q36922108-43D26EEA-9D97-497C-BE09-DF33ACEEC782Q38150408-2EC8E4E5-49DA-4AB7-9307-223CDAE7C9ADQ38178032-A56B3940-7945-44DA-93AC-6085F69D3FD6Q38642925-9DB9F799-EF3B-4893-AE66-2F988494CFF5Q38675948-EC3EB5C3-7D0D-4938-8076-827ACCBA1708Q38728458-C4588552-A71C-47AE-8A4F-B563B7E0EC76Q38765115-32BE5CE0-D1FD-403F-A4F9-937EBE252ABEQ38825737-1834421A-61B5-4E46-B5D8-D7A6C41D625FQ38888305-26F692F9-E260-4496-A161-3DCC76876A5DQ39254523-8629AA61-410F-4F96-8981-454A6D5A15F2Q39376604-735F04C2-FA63-40AC-BA2F-119B702157E7Q40252077-85D15A4E-FD12-4B42-A5EF-31CC532F4160Q40422363-267718B5-5368-4CA2-BDA7-33E97387C896Q40788968-4353C813-B1AB-4045-A5D5-D8A6D2D1D630Q45864098-5DB089D0-A385-44B6-8390-6072028D93DFQ50063376-411331C9-DAF8-413F-95D3-8E666F71DAF6Q54206537-2EE072F9-FE9C-4710-95D9-0D1DE3A55569Q58744094-13266C3B-1622-4CE2-85E2-A06B7F8846C4
P2860
Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis.
@ast
Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis.
@en
type
label
Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis.
@ast
Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis.
@en
prefLabel
Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis.
@ast
Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis.
@en
P2093
P2860
P356
P1476
Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis.
@en
P2093
Blair U Bradford
Garrett R Ainslie
Gary A Boorman
Igor P Pogribny
Ivan Rusyn
Jyoji Yamate
Kristi Kutanzi
Levan Muskhelishvili
Oksana Kosyk
Ramon Bataller
P2860
P356
10.1093/TOXSCI/KFS342
P577
2013-01-03T00:00:00Z